Klin Monbl Augenheilkd 2023; 240(02): 163-168
DOI: 10.1055/a-1942-2007
Klinische Studie

Effect of Intense Pulsed Light to Mitigate Meibomian Gland Dysfunction for Dry Eye Disease

Wirkung von intensivem gepulstem Licht zur Linderung der Meibom-Drüsen-Dysfunktion für das Trockene-Auge-Syndrom
Abhishek Suwal
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
,
Jilong Hao
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
,
Xiufen Liu
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
,
Dandan Zhou
2   Department of Radiology, The First Hospital of Jilin University, Changchun, China
,
Zhifang Jia
3   Division of Clinical Research, The First Hospital of Jilin University, Changchun, China
,
Hongwei Liu
4   Ophthalmology, Jiamusi University First Affiliated Hospital, Jiamusi, China
,
Yu Ren
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
,
Fei Shao
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
,
1   Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China
› Institutsangaben

Abstract

Background This retrospective study aimed to evaluate the effect of intense pulsed light treatment (IPL) combined with meibomian gland expression (MGX) in treating meibomian gland dysfunction (MGD) related dry eye disease (DED) for the first time in Northeast China.

Methods Thirty-one MGD-related dry eye patients were managed by IPL-MGX from October to December 2019 in The First Hospital of Jilin University. Those patients had single IPL-MGX treatment with one follow-up visit, and no topical eye drops used were included in the study. General checkup and data collection helped in determining the age, sex, diagnosis, status of the MG, first noninvasive tear break-up time (1st NIBUT), average NIBUT, the height of tear film, and additional medical history.

Results There was an improvement in the function of the meibomian gland (MG), with a significant decrease in the MG dropouts in the upper eyelid (Rt eye, p = 0.0047; Lt eye, p = 0.0158) and lower eyelid (Rt eye, p = 0.0017; Lt eye, p = 0.0027) plus the average NIBUT (Rt eye, p = 0.0264) also showed improvement after the IPL-MGX treatment. Though no significant difference was reached with the average NIBUT of the Lt eye (p = 0.5256) and the NIBUT grade (Rt eye, p = 0.0578; Lt eye, p = 0.0588), there was an increased duration of the average NIBUT and improved NIBUT grading. The negative results may be because of the maximum severity of DED and the limited treatment times.

Conclusions The result suggests that IPL-MGX was effective in treating MGD-related DED.

Zusammenfassung

Hintergrund Diese retrospektive Studie zielt darauf ab, die Wirkung einer Behandlung mit intensiv gepulstem Licht (IPL) in Kombination mit der Meibom-Drüsen-Expression (MGX) bei der Behandlung der Meibom-Drüsen-Dysfunktion (MGD) im Zusammenhang mit dem Trockenen Auge (DED) zum ersten Mal in Nordostchina zu bewerten.

Methoden 31 Patienten mit Trockenem Auge im Zusammenhang mit MGD wurden von Oktober bis Dezember 2019 im Ersten Krankenhaus der Jilin-Universität mit IPL-MGX behandelt. Diese Patienten erhielten eine einzige IPL-MGX-Behandlung mit einem Folgebesuch, und es wurden keine topischen Augentropfen in die Studie aufgenommen. Die allgemeine Untersuchung und Datenerfassung half bei der Bestimmung von Alter, Geschlecht, Diagnose, Status der MG, Zeit der ersten nicht invasiven Tränenfilmunterbrechung (1. NIBUT), durchschnittlicher NIBUT, Höhe des Tränenfilms und zusätzlicher Krankengeschichte.

Ergebnisse Es gab eine Verbesserung der Funktion der Meibom-Drüse (MG) mit einer signifikanten Abnahme der MG-Aussetzer im oberen Augenlid (rechtes Auge, p = 0,0047; linkes Auge, p = 0,0158) und im unteren Augenlid (rechtes Auge, p = 0,0017; linkes Auge, p = 0,0027) plus die durchschnittliche NIBUT (rechtes Auge, p = 0,0264) zeigte ebenfalls eine Verbesserung nach der IPL-MGX-Behandlung. Obwohl kein signifikanter Unterschied zwischen der durchschnittlichen NIBUT auf dem linken Auge (p = 0,5256) und dem NIBUT-Grad (rechtes Auge, p = 0,0578; linkes Auge, p = 0,0588) erreicht wurde, gibt es eine längere Dauer der durchschnittlichen NIBUT und eine verbesserte NIBUT-Einstufung. Die negativen Ergebnisse können auf den maximalen Schweregrad der KCS und die begrenzten Behandlungszeiten zurückzuführen sein.

Schlussfolgerungen Das Ergebnis legt nahe, dass IPL-MGX bei der Behandlung von MGD-bedingter KCS wirksam war.



Publikationsverlauf

Eingereicht: 23. Mai 2022

Angenommen: 10. September 2022

Accepted Manuscript online:
13. September 2022

Artikel online veröffentlicht:
27. November 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Knop N, Knop E. [Meibomian glands. Part I: anatomy, embryology and histology of the Meibomian glands]. Ophthalmologe 2009; 106: 872-883
  • 2 Nelson JD, Shimazaki J, Benitez-del-Castillo JM. et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 2011; 52: 1930-1937
  • 3 Giannaccare G, Taroni L, Senni C. et al. Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives. Clin Optom (Auckl) 2019; 11: 113-126
  • 4 Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg 2015; 33: 41-46
  • 5 Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea 2016; 35: 318-322
  • 6 Dell SJ, Gaster RN, Barbarino SC. et al. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Optom (Auckl) 2017; 11: 817
  • 7 Craig JP, Nelson JD, Azar DT. et al. TFOS DEWS II Report Executive Summary. Ocul Surf 2017; 15: 802-812
  • 8 Fernandez J, Rodriguez-Vallejo M, Martinez J. et al. Agreement and repeatability of objective systems for assessment of the tear film. Graefes Arch Clin Exp Ophthalmol 2018; 256: 1535-1541
  • 9 Aketa N, Shinzawa M, Kawashima M. et al. Efficacy of plate expression of meibum on tear function and ocular surface findings in meibomian gland disease. Eye Contact Lens 2019; 45: 19-22
  • 10 Schaumberg DA, Nichols JJ, Papas EB. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011; 52: 1994-2005
  • 11 Green-Church KB, Butovich I, Willcox M. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 2011; 52: 1979-1993
  • 12 Wu H, Wang Y, Dong N. et al. Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers. PLoS One 2014; 9: e105575
  • 13 Lu CW, Fu J, Liu XF. et al. Air pollution and meteorological conditions significantly contribute to the worsening of allergic conjunctivitis: a regional 20-city, 5-year study in Northeast China. Light Sci Appl 2021; 10: 190
  • 14 Li D, Lin SB, Cheng LH. et al. Intense Pulsed Light Treatment for Itch Associated with Allergic Keratoconjunctivitis: A Retrospective Study of 35 Cases. Photobiomodul Photomed Laser Surg 2021; 39: 196-203
  • 15 Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2015; 56: 1965-1970
  • 16 Yin Y, Liu N, Gong L. et al. Changes in the Meibomian Gland After Exposure to Intense Pulsed Light in Meibomian Gland Dysfunction (MGD) Patients. Curr Eye Res 2018; 43: 308-313
  • 17 Arita R, Mizoguchi T, Fukuoka S. et al. Multicenter Study of Intense Pulsed Light Therapy for Patients With Refractory Meibomian Gland Dysfunction. Cornea 2018; 37: 1566-1571
  • 18 Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye (Lond) 2011; 25: 502-510
  • 19 Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf 2019; 17: 104-110